Pulmonary squamous cell carcinoma and sorafenib

KEY CLINICAL MESSAGE: Pulmonary squamous cell carcinomas are not often thought to sensitive to targeted agents, like their cousin the adenocarcinoma of the lung. With appropriate testing of molecular markers, squamous cell carcinomas, like adenocarcinomas of the lung, melanomas, and renal cell carci...

Descripción completa

Detalles Bibliográficos
Autores principales: Gollard, Russell, Garcia, Diana, Natale, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302627/
https://www.ncbi.nlm.nih.gov/pubmed/25614813
http://dx.doi.org/10.1002/ccr3.95
_version_ 1782353839952756736
author Gollard, Russell
Garcia, Diana
Natale, Ron
author_facet Gollard, Russell
Garcia, Diana
Natale, Ron
author_sort Gollard, Russell
collection PubMed
description KEY CLINICAL MESSAGE: Pulmonary squamous cell carcinomas are not often thought to sensitive to targeted agents, like their cousin the adenocarcinoma of the lung. With appropriate testing of molecular markers, squamous cell carcinomas, like adenocarcinomas of the lung, melanomas, and renal cell carcinomas, may be found to be sensitive to newer, targeted agents.
format Online
Article
Text
id pubmed-4302627
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-43026272015-01-22 Pulmonary squamous cell carcinoma and sorafenib Gollard, Russell Garcia, Diana Natale, Ron Clin Case Rep Case Reports KEY CLINICAL MESSAGE: Pulmonary squamous cell carcinomas are not often thought to sensitive to targeted agents, like their cousin the adenocarcinoma of the lung. With appropriate testing of molecular markers, squamous cell carcinomas, like adenocarcinomas of the lung, melanomas, and renal cell carcinomas, may be found to be sensitive to newer, targeted agents. Blackwell Publishing Ltd 2014-10 2014-07-25 /pmc/articles/PMC4302627/ /pubmed/25614813 http://dx.doi.org/10.1002/ccr3.95 Text en © 2014 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Gollard, Russell
Garcia, Diana
Natale, Ron
Pulmonary squamous cell carcinoma and sorafenib
title Pulmonary squamous cell carcinoma and sorafenib
title_full Pulmonary squamous cell carcinoma and sorafenib
title_fullStr Pulmonary squamous cell carcinoma and sorafenib
title_full_unstemmed Pulmonary squamous cell carcinoma and sorafenib
title_short Pulmonary squamous cell carcinoma and sorafenib
title_sort pulmonary squamous cell carcinoma and sorafenib
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302627/
https://www.ncbi.nlm.nih.gov/pubmed/25614813
http://dx.doi.org/10.1002/ccr3.95
work_keys_str_mv AT gollardrussell pulmonarysquamouscellcarcinomaandsorafenib
AT garciadiana pulmonarysquamouscellcarcinomaandsorafenib
AT nataleron pulmonarysquamouscellcarcinomaandsorafenib

Ejemplares similares